David B. Colleran EVP

David B. Colleran EVP

General Counsel and SecretaryatAnika Therapeutics· In proxies 2023–2025

Pay in FY2025-3% from the year before · Anika Therapeutics stock -41.6% the same year

David B. Colleran EVP was paid $1.6M in FY2025 (Dec), down 3%. Anika Therapeutics stock fell 41.6% that year.

Pay$100 in the stock at the end of FY22 → $32
Pay is from the Summary Compensation Table of each Anika Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Anika TherapeuticsPublic company · 3 yr
    • General Counsel and Secretary2023 – Present · 3 yrStock in role -24%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?